Next Article in Journal
TGF-β Sustains Tumor Progression through Biochemical and Mechanical Signal Transduction
Next Article in Special Issue
Designer Oncolytic Adenovirus: Coming of Age
Previous Article in Journal
Antiviral Drugs for EBV
Previous Article in Special Issue
Regulation of Constitutive Interferon-Stimulated Genes (Isgs) in Tumor Cells Contributes to Enhanced Antitumor Response of Newcastle Disease Virus-Infected Tumor Vaccines
Open AccessReview

Oncolytic Viruses for Multiple Myeloma Therapy

1
Division of Translational and Regenerative Medicine, Department of Medicine and The University of Arizona Cancer Center, Tucson, AZ 85724, USA
2
Jane Anne Nohl Division of Hematology and Center for the Study of Blood Diseases, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, CA 90033, USA
3
Division of Hematology and Oncology, University of Arizona Cancer Center, Tucson, AZ 85724, USA
*
Author to whom correspondence should be addressed.
Cancers 2018, 10(6), 198; https://doi.org/10.3390/cancers10060198
Received: 3 May 2018 / Revised: 31 May 2018 / Accepted: 12 June 2018 / Published: 14 June 2018
(This article belongs to the Special Issue Oncolytic Virotherapy)
Although recent treatment advances have improved outcomes for patients with multiple myeloma (MM), the disease frequently becomes refractory to current therapies. MM thus remains incurable for most patients and new therapies are urgently needed. Oncolytic viruses are a promising new class of therapeutics that provide tumor-targeted therapy by specifically infecting and replicating within cancerous cells. Oncolytic therapy yields results from both direct killing of malignant cells and induction of an anti-tumor immune response. In this review, we will describe oncolytic viruses that are being tested for MM therapy with a focus on those agents that have advanced into clinical trials. View Full-Text
Keywords: multiple myeloma; oncolytic virotherapy; reovirus; measles virus; vesicular stomatitis virus; vaccinia virus; myxoma virus; adenovirus multiple myeloma; oncolytic virotherapy; reovirus; measles virus; vesicular stomatitis virus; vaccinia virus; myxoma virus; adenovirus
Show Figures

Figure 1

MDPI and ACS Style

Calton, C.M.; Kelly, K.R.; Anwer, F.; Carew, J.S.; Nawrocki, S.T. Oncolytic Viruses for Multiple Myeloma Therapy. Cancers 2018, 10, 198.

Show more citation formats Show less citations formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop